1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Haematological Malignancy: new trials by email Literature Review of Haematological Malignancy trials Research Report on Haematological Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation Nivolumab Injection - Haematological Malignancy | Phase 2 | Unknown | Melbourne Health | 14 | 2017-05-08 | 2021-09-23 |
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Neoplasms (1) · Neoplasms by Site (1)
Nivolumab (1)
Melbourne Health (1)
Australia (1)